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Abstract
The guanine nucleotide exchange factor, C3G (RapGEF1), functions in multiple signaling pathways involved in cell adhesion,
proliferation, apoptosis and actin reorganization. C3G is regulated by tyrosine phosphorylation on Y504, known to be
mediated by c-Abl and Src family kinases. In the present study we explored the possibility of cellular phospho-C3G (pC3G)
being a substrate of the intracellular T-cell protein tyrosine phosphatase TC-PTP (PTPN2) using the human neuroblastoma
cell line, IMR-32. In vivo and in vitro binding assays demonstrated interaction between C3G and TC-PTP. Interaction is
mediated through the Crk-binding region of C3G and C-terminal noncatalytic residues of TC-PTP. C3G interacted better with
a substrate trap mutant of TC48 and this complex formation was inhibited by vanadate. Endogenous pC3G colocalized with
catalytically inactive mutant TC48 in the Golgi. Expression of TC48 abrogated pervanadate and c-Src induced
phosphorylation of C3G without affecting total cellular phospho-tyrosine. Insulin-like growth factor treatment of c-Src
expressing cells resulted in dephosphorylation of C3G dependent on the activity of endogenous TC48. TC48 expression
inhibited forskolin induced tyrosine phosphorylation of C3G and neurite outgrowth in IMR-32 cells. Our results identify a
novel Golgi localized substrate of TC48 and delineate a role for TC48 in dephosphorylation of substrates required during
differentiation of human neuroblastoma cells.
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Introduction
Signals initiated by transmembrane receptors at the cell surface
are transmitted through the activity of guanine nucleotide
exchange factors (GEFs) responsible for activation of small
GTPases. Through their action on multiple effector molecules,
GTPases enable regulation of diverse cellular functions like
proliferation, actin reorganization, adhesion, motility, apoptosis
and differentiation. The ubiquitously expressed GEF, C3G
(RapGEF1, GRF2) functions in signaling pathways initiated by
growth factors, integrins, T and B-cell receptors, cytokines,
mechanical force etc and is known to target Rap1, 2, R-Ras and
TC-10 [1–8]. C3G plays a role in regulating cell proliferation,
apoptosis, actin reorganization, neuronal differentiation, and is
essential during embryonic development [9–14].
C3G is a 140 kDa protein that primarily possesses a catalytic
domain at the extreme C-terminus responsible for guanine
nucleotide exchange and a central region comprising of multiple
proline-rich sequences involved in protein interaction [15,16].
SH3 domain containing molecules like Crk, Hck, p130 Cas and c-
Abl have been shown to interact with C3G through this domain
[10,11,15–17]. Within this domain are also present several
tyrosine residues, and Y504 is targeted by Src family kinases
(SFKs) and c-Abl [10,18,19]. The N-terminal domain of C3G is
poorly defined except for sequences responsible for interaction
with E-cadherin [20]. Catalytic activity of C3G is regulated
through Y504 phosphorylation and membrane targeting [21,22].
C3G suppresses malignant transformation independent of its
catalytic activity [23]. In signaling pathways, C3G therefore has
functions dependent on both its catalytic activity and interaction
domain.
Knockout mice lacking C3G are embryonic lethal and show
defects in multiple systems like vascular maturation and neural
cortical development [13,24,25]. We have demonstrated that C3G
signals to actin reorganization and is required for differentiation of
human neuroblastoma cells [12]. Stimulation of ALK, a receptor
tyrosine kinase, results in tyrosine phosphorylation of C3G and
neurite growth in PC12 cells [26]. Cells differentiated by
neurotrophin treatment show enhanced C3G protein levels and
Src family kinase dependent phosphorylation of C3G on Y504
[12]. Phospho-C3G (pC3G) under these conditions localizes
predominantly at the Golgi. Since phospho-tyrosine dependent
signaling is also under the control of tyrosine phosphatases, we
wished to identify enzymes that regulate C3G phosphorylation
and its downstream effector functions.
PLoS ONE | www.plosone.org 1 August 2011 | Volume 6 | Issue 8 | e23681The T-cell protein tyrosine phosphatase (TC-PTP) is an
intracellular PTPase expressed as two alternately spliced isoforms
TC48 and TC45, which differ only in their C-termini [27,28].
TC48 is localized to the nuclear membrane, endoplasmic
reticulum and Golgi [27–29]. p23 and p25, proteins of a family
of cargo receptors were identified as specific interacting partners of
TC48 and enable its dynamic exchange between ER and Golgi
compartment [29]. TC45 is present in the nucleus and is known to
exit the nucleus in response to some types of stress and growth
factor stimulation [30–34]. TC-PTP deficient mice show defects in
development of the hematopoietic system and in inflammatory
responses [35]. TC-PTP is ubiquitously expressed and has
functions in insulin signaling [36]. Its role in other cells and
tissues is yet to be determined. Identification of TC-PTP substrates
has been important in understanding its physiological functions.
While a large number of cellular substrates have been identified
for TC45, very few TC48 substrates are known [37]. Since
subcellular localization plays an important role in determining
substrate specificity [38], in this study, we investigated the ability
of TC-PTP isoforms to dephosphorylate cellular C3G in human
neuroblastoma cells. Our results identify C3G as a novel
interacting partner and substrate of TC48. We also describe a
functional significance for TC48 mediated dephosphorylation in
differentiation of human neuroblastoma cells.
Materials and Methods
Cell lines and transfections
IMR-32, human neuroblastoma cells, HEK293, human em-
bryonic kidney cells and Cos-1, monkey kidney epithelial cells,
obtained from ATCC were maintained in DMEM containing
10% FCS at 37uC in a humidified incubator with 5% CO2. Cells
were grown as monolayers in dishes for lysate preparation or on
coverslips for immunofluorescence. Transfection of IMR-32 cells
and Cos-1 cells were performed as described [12,18]. Generally
400 ng of DNA was used to transfect cells on coverslips or in 24
well plates and 4 mg was used for cells in 60 mm dishes. Transient
transfection was carried out for 30–48 hours. Cells were treated
with 50 mM sodium vanadate for 4 hrs or with 50 mM
pervanadate for 10 min prior to fixation or lysate preparation.
IGF (100 ng/ml) treatment was performed for 4 hrs after
subjecting cells to serum starvation by incubating them in
serum-free medium for 8–10 hrs. Forskolin treatment for
differentiation of IMR-32 cells was carried out as described earlier
[12].
Expression vectors and antibodies
Plasmids for expression of full length C3G, Y504FC3G, GST-
CBR, GFP-c-Src, c-Src, GFP-TC48, GFP-TC45, GFP-TC48-C-
66, and GFP-p23 have been described earlier [11,18,29]. Y504F
C3G is a phosphorylation site mutant. GST-CBR is a recombi-
nant protein with the Crk binding region of C3G fused to GST.
GFP-TC45-C38 is a deletion construct of TC45 containing C-
terminal residues 350-387 cloned in pEGFP vector. Mutant TC48
and TC45 were created by substituting aspartic acid at 182 to
alanine using site-directed mutagenesis (D182A, mTC48/
mTC45). These mutants lack catalytic activity and function as
dominant negatives as well as substrate traps [38,39].
Antibodies against C3G (C-19); pC3G (pY504-C3G), c-Src,
Cdk2, p-Tyr and GFP were from Santa Cruz. TC-PTP antibody
which recognizes both human isoforms was from Calbiochem.
ERGIC-53 antibody was from Axxora, and giantin antibody was
from Covance.
Immunoprecipitation, in vitro binding assays and
western blotting. Immunoprecipitations were carried out
essentially as described [11,29]. Lysates prepared from HEK293
cells expressing C3G and GFP-TC-PTP constructs, or mTC48
alone were incubated with equal amounts of GFP antibody or
control mouse IgG. Immune complexes were isolated using
protein A/G plus agarose beads and subjected to western
blotting using C3G and GFP antibodies. Expression of GST-
C3G-CBR fusion protein and in vitro binding assays were
performed as described [11]. Lysates of HEK293 cells
expressing various TC-PTP constructs were used for in vitro
binding. Western blotting was carried out using standard
protocols. Conditions for Western blotting of pC3G have been
described [10,18]. About 50 mg of lysates were loaded to visualize
the proteins by western blot. Probing using multiple antibodies was
carried out after deprobing.
Indirect immunofluorescence and quantitation of neurite
outgrowth
Expression and localization of overexpressed or endogenous
protein was determined in cells grown on coverslips. Essentially,
cells were fixed in 3.7% formaldehyde in PBS for 10 mins and
processed for staining as described [18,19]. Secondary antibodies
coupled to Cy3, Cy5, Alexa-488 or Alexa-633 were used.
Sequential staining was carried out to detect the presence of two
different proteins. Co-localization was examined by analyzing
optical sections in the Z-axis using 63X oil immersion objective of
a confocal microscope (Leica). Images were also captured using
40X objective of Zeiss Axioplan 2 microscope fitted with an
Apotome.
Effect of TC-PTP on neurite outgrowth (NOG) in IMR-32 cells
was determined by transfecting GFP-TC48 or mTC48 plasmids
and inducing differentiation by 25 mM forskolin treatment for
72 hrs. NOG was quantitated as described by determining the
number of cells with extensions greater than 2 cell diameters
among the GFP expressing and non-expressing cells [12]. Data
was averaged from a minimum of 3 experiments carried out on
duplicate cover slips and represented as mean 6 sd. Significance
of the data was determined using Students ‘t’ test.
Results
C3G interacts with TC48
As a first step towards exploring the functional regulation of
C3G by TC-PTP, possible interaction between C3G and TC48
was tested by examining the ability of C3G to co-precipitate with a
catalytically inactive substrate trap mutant, mTC48 (D182A).
Mutant enzymes have been used to study interaction between
tyrosine phosphatases and their substrates [37]. It was seen that
exogenously expressed (Fig. 1B) as well as cellular C3G (Fig. 1C)
co-precipitated with the mutant enzyme, indicating that C3G and
TC48 interact physically in vivo. We have earlier shown that
cellular C3G is phosphorylated on Y504 upon treatment of cells
with pervanadate (PV) [18]. In cells stimulated with PV,
interaction between C3G and mTC48 was competed out by
sodium orthovanadate, a phosphotyrosine mimetic, suggesting
direct binding (Fig. 1D). No interaction is seen between
overexpressed C3G and GFP used as a control.
TC48 has earlier been shown to localize to the Golgi and ER
[28,29]. In IMR-32 cells too, it was observed that TC48 shows
predominant localization in the Golgi region of the cell as
evidenced by co-staining with Golgi marker, Giantin and
ERGIC marker, ERGIC53 (Fig. S2). We also examined the
possible colocalization of C3G and TC48 in human neuroblas-
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colocalization in the cytoplasmic compartment in confocal
sections through the centre of the nucleus. While TC48 showed
juxta nuclear prominence, C3G was distributed throughout the
cytoplasm with weaker presence in the area of the Golgi (Fig. 1E).
This pattern suggested that C3G does not localize at the Golgi
and is mostly cytosolic. C3G and the TC45 variant showed
mutually exclusive localization with the later present only in the
nucleus.
Ability of C3G and TC48 to interact directly was examined in
an in vitro pull down assay using a fusion protein of GST coupled to
the Crk binding region of C3G encompassing 268-648 residues of
C3G (GST-CBR), shown in Fig. 1A. Lysates of HEK293 cells
expressing GFP, GFP-TC48 or GFP-TC45 were incubated with
GST or GST-CBR coupled to glutathione-agarose beads. As
shown in Fig. 2A, GFP-TC48 and GFP-TC45 interacted
specifically with GST-CBR but not with GST alone. GFP did
not interact with GST or the recombinant fusion protein. TC48
Figure 1. C3G interacts with TC-PTP: (A) Schematic showing domain organization of C3G and the two splice variants of TC-PTP, TC48 and TC45 as
GFP fusion proteins. Fusion proteins of GFP with C-terminal sequence of TC48 and TC45 are also shown. Recombinant GST fusion protein of the Crk
binding region of C3G is also shown (GST-CBR). (B) C3G co-precipitates with mTC48 from cell lysates. HEK-293 cells transfected with C3G and GFP-
mTC48 were subjected to immunoprecipitation using control mouse IgG or GFP antibodies. The immunoprecipitates were analyzed for western
blotting with C3G and GFP antibodies. Whole cell lysates (WCL) used for immunoprecipitation are also included to show expression of the protein.
* indicates partially degraded mTC48 in lysates during immunoprecipitation. (C) Interaction of mTC48 with cellular C3G. Experiment was carried out
as in (B) using lysates of cells transfected with mTC48 alone. (D) Interaction of mTC48 with C3G is abrogated by vanadate. GFP-mTC48 was
immunoprecipitated from lysates of HEK293 cells expressing C3G and GFP-mTC48, left untreated (Utr) or treated with 50mM vanadate (VO4) for 4 hrs.
Cells were subjected to 10 min treatment with PV to stimulate C3G phosphorylation prior to lysis. Along with lysates (WCL), the immunoprecipitates
were subjected to Western blotting with the indicated antibodies. Immunoprecipitation was also carried out from cells expressing GFP and C3G as a
control. (E) Sub-cellular localization of C3G and TC-PTP. IMR-32 cells transfected with C3G and either GFP-TC48 or GFP-TC45 were stained for C3G and
analyzed by confocal microscopy. A section through the centre of the nucleus is shown. Bar, 10 mm.
doi:10.1371/journal.pone.0023681.g001
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of hydrophobic sequences through which it is known to
oligomerize and interact specifically with other proteins
[27,29,40]. Using a deletion construct of TC48, GFP-C66 in in
vitro pull down assays, we observed that C-terminal residues of
TC48 (350-416) are sufficient for interaction with C3G (Fig. S1).
Since TC45 also showed interaction in these assays it could be
inferred that the hydrophobic unique residues in TC48 are not
essential for the interaction. These results implied that residues
between 350 and 381 at the C-terminus of TC-PTP which are
present in both isoforms may be responsible for interaction with
CBR domain of C3G. This was examined by testing for
interaction between a GFP fusion protein containing C-terminal
38 residues of TC45 (350-387) with GST-CBR. Fig. 2B shows that
C-terminal 38 residues in TC45 are sufficient for specific
interaction with C3G-CBR. The absence of non-specific interac-
tion was seen by the lack of interaction of GST with C38 and also
lack of interaction of GST-CBR with a cellular protein, Cdk2.
From the multiple in vitro interaction assays performed, it was seen
that the C-terminal deletion constructs showed weaker affinity for
GST-CBR compared to the full length PTP isoforms.
Endogenous C3G is phosphorylated on Y504 in response to
forskolin or NGF treatment of IMR-32 cells and pC3G shows Golgi
localization[12].Thisphosphorylationwasshowntobemediatedby
SFKs. IMR-32 cells subjected to PV treatment which activates
SFKs, also induced phosphorylation of endogenous C3G specifically
on Y504, detected using the phospho-specific antibody pY504-C3G
(Fig. 3A). This antibody does not interact with the large number of
other cellular proteins phosphorylated on tyrosine in response to PV
treatment, detected using pTyr antibody. The specificity of this
antibody to detect C3G phosphorylated on Y504 but not other
tyrosine residues was also shown by immunoprecipitating C3G and
Y504F mutant from cells co-expressing c-Src tyrosine kinase and
immunoblotting with pC3G and pTyr antibodies. Fig. S3A shows
that the pC3G antibody detects only WT C3G phosphorylated by
Src, but not the Y504F mutant. This mutant showed reactivity with
pTyr antibodies indicating that tyrosine residues of C3G other than
Y504 are phosphorylated by Src. The specificity of the pC3G
antibody to detect C3G phosphorylated on Y504 in indirect
immunofluorescence is shown in Fig. S3B. PV activated cellular
kinases to phosphorylate both endogenous as well as overexpressed
C3G (detected as cytoplasmic staining corresponding with C3G
expression) whereas overexpressed Y504F mutant expressing cells
showed no enhanced pC3G staining.
Endogenous pC3G localization was examined by indirect
immunofluorescence in cells transfected with GFP- p23, a protein
that localizes to the Golgi [29]. PV induced pC3G co-localized
with GFP- p23 at the Golgi (Fig. 3B). The colocalization of pC3G
with TC48 was tested in cells transfected with a catalytically
inactive mutant TC48 (mTC48) upon treatment with PV. As seen
in Fig. 3C, pC3G colocalizes with mTC48 in the core of the Golgi.
PV induced phosphorylation of C3G was reversible and subject to
the action of cellular tyrosine phosphatases. Upon removal of PV
and incubation with cDMEM for 4 hours, cells showed loss of
pC3G staining (Fig. S4). pC3G staining was more prominent when
PV treated cells were incubated with cDMEM containing 50 mM
VO4 indicating that cellular tyrosine phosphatases could dephos-
phorylate C3G.
TC48 expressing cells do not show pC3G induced by PV
or SFKs
Co-immunoprecipitation experiments which showed interaction
between C3G and the substrate trap mutant phosphatase and the
sensitivity of this interaction to vanadate, suggested that C3G may
be a substrate of TC-PTP. This was examined by observing the
presence of pC3G in IMR-32 cells expressing either GFP, or GFP
tagged TC45, mTC45, TC48 & mTC48 after being subjected to
PV treatment. As shown in Fig. 4, cells expressing GFP, TC45,
mTC45 or mTC48 showed no affect on pC3G staining, whereas
TC48 expressing cells lacked the presence of pC3G in the Golgi.
Cells that were not treated with PV showed total absence of any
Figure 2. C-terminal residues of TC-PTP are responsible for
direct interaction with CBR domain of C3G. (A) In vitro interaction
between C3G and TC-PTP. GST and GST-CBR coupled to glutathione
agarose beads were incubated with lysates of HEK-293 cells expressing
GFP, GFP-TC45 or GFP-TC48. The WCL and washed beads were subjected
to western blotting for GFP. The recombinant protein levels are shown in
the Ponceau stained blot. M, protein molecular weight markers.
* indicates position of GFP and the GFP fusion proteins. (B) C3G Crk
binding region interacts with C-terminal regulatory sequences of TC-PTP.
TC48 and a deletion construct of TC45, GFP-C38 (schematic shown in Fig.
1A) were used in in vitro interaction assay as described in (A).
doi:10.1371/journal.pone.0023681.g002
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may be dephosphorylating Y504 phosphorylated C3G induced by
PV treatment, but the nuclear TC45, does not act on C3G.
Expression of HA-TC45, that can exit the nucleus in response to
certain stimuli, also did not affect PV induced cytoplasmic
phospho-C3G (Fig. S5A). Under similar conditions HA-TC48
caused dephosphorylation of C3G.
To rule out a possibility for cell type specific effects with respect
to targets of TC-PTP, the ability of TC48 to dephosphorylate
C3G was also examined in Cos-1 cells. PV treatment resulted in
phosphorylation of C3G in cells expressing TC45 or mTC48, but
not in cells expressing wild-type TC48 (Fig. S5B). No difference
was seen in overall pTyr staining induced by PV in cells expressing
TC45 or TC48 compared to non-expressing cells (Fig. S5C).
These results indicated the specificity of C3G as a substrate for
TC48 and that TC48 does not act on cellular pTyr in general due
to overexpression.
Neurotrophin signaling is mediated through Src and we have
earlier shown that SFKs can phosphorylate C3G at Y504 which
then predominantly localizes to the Golgi [12,18]. c-Src
expression was therefore used to study the dynamics of
endogenous C3G phosphorylation. Y504 phosphorylated C3G
was seen only in lysates of cells co-expressing WT-C3G with Src
and not in Y504F mutant expressing cells (Fig. 5A). GFP-c-Src
expression in IMR-32 cells, resulted in phosphorylation of
endogenous C3G detected in Western blots by giving longer
exposures (Fig. 5B). GFP-c-Src showed prominent Golgi
localization and Src expressing cells show the presence of
pC3G in the Golgi (Fig. 5C). In c-Src and mTC48 expressing
cells, pC3G colocalizes with these two proteins in the juxta-
nuclear region (Fig. 5D). The ability of TC-PTP to dephosphor-
ylate C3G phosphorylated by c-Src was tested by co-expressing c-
Src with either pCDNA or the TC-PTP constructs and observing
the presence of pC3G in indirect immunofluorescence and
western blotting. As shown in Fig. 5E, lysates from cells
expressing c-Src with pCDNA showed the presence of pC3G,
but lysates from cells co-expressing TC48 did not show the
presence of any pC3G. Cells expressing mTC48 showed higher
levels of pC3G relative to control lysates indicating that mTC48
may be inhibiting the activity of endogenous TC48 by
functioning as a dominant negative. Expression of GFP-Src,
GFP-TC48 and GFP-mTC48 was confirmed by probing the blot
with GFP (Fig. 5E). Examination of cells expressing c-Src also
showed the absence of pC3G in wild type TC48 co-expressing
cells whereas TC45 expression did not affect pC3G staining
(Fig. 5F). Dephosphorylation of pC3G by TC48 appeared to be
Figure 3. Pervanadate (PV) treatment induces Y504 phosphorylation of C3G and pC3G localizes to the Golgi. (A) IMR-32 cells were
subjected to PV treatment and lysates used in Western blotting for pC3G, C3G, pTyr and Cdk2 (as loading control). (B) IMR-32 cells growing on
coverslips were transfected with GFP-p23, subjected to PV treatment and stained for pC3G. Panels show images of cells captured using a
fluorescence microscope fitted with an apotome. Bar, 10 mm. (C) pC3G co-localizes with TC48 at the Golgi. IMR-32 cells expressing GFP- mTC48 were
subjected to PV treatment and stained for pC3G. Panels show a single section in the Z-axis captured using a confocal microscope. Utr, untreated, PV,
pervanadate treated. Bar, 10 mm.
doi:10.1371/journal.pone.0023681.g003
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proteins was not affected by expression of either TC48 or TC45
(Fig. S6).
C3G dephosphorylation due to action of TC48, was confirmed
by treating TC48 expressing cells with VO4 for 4 hrs prior to
lysate preparation or fixation. The phosphorylation of C3G was
Figure 4. TC48 expression inhibits PV induced C3G phosphorylation. IMR-32 cells expressing GFP, GFP-TC48, GFP-mTC48, GFP-TC45 or GFP-
mTC45 were subjected to PV treatment and stained for pC3G. Utr, Untreated. Bar, 10 mm.
doi:10.1371/journal.pone.0023681.g004
Figure 5. TC48 inhibits c-Src induced C3G phosphorylation. (A) Lysates of HEK293 cells expressing GFP-Src along with either pCDNA, C3G or
Y504F mutant were subjected to western blotting with the indicated antibodies. (B) IMR-32 cells transfected with GFP-c-Src were subjected to
western blotting to detect endogenous C3G phosphorylated on Y504. Blots were exposed longer compared to those in 4A, where endogenous pC3G
is not detected. (C) GFP-c-Src expressing IMR-32 cells were stained for pC3G to visualize localization pattern. (D) IMR-32 cells transfected with GFP-
mTC48 and c-Src were stained for indirect immunofluorescence using Src and pC3G antibodies. (E) GFP-c-Src was co-expressed with either pCDNA,
GFP-mTC48 or GFP-TC48 in IMR-32 cells and lysates subjected to western blotting as indicated. (F) In situ expression of pC3G in IMR-32 cells
expressing c-Src along with pCDNA, GFP-mTC48, GFP-TC48 or GFP-TC45. Bar, 10 mm.
doi:10.1371/journal.pone.0023681.g005
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along with GFP-Src, mutant or WT TC48. Src as well as TC48
were seen in C3G immunoprecipitates suggesting that C3G could
form a trimolecular complex containing both the kinase and the
phosphatase in cells (Fig. 6A). Co-expression of WT TC48
decreased Y504 phoshorylation of C3G significantly compared to
that seen in mutant TC48 expressing cells.
VO4 treatment inhibited the ability of TC48 to dephosphorylate
C3G. TC48 expression did not affect p-Tyr levels of Src. It was
observed that mTC48 interacts better with C3G compared to the
WT enzyme. No significant difference was seen in interaction of
WT TC48 with C3G in the presence of VO4. pC3G was detected
by indirect immunoflourescence in c-Src expressing cells irrespec-
tive of the presence or absence of TC48 expression in vanadate
treated cells (Fig. 6B).
c-Src induced pC3G is dephosphorylated by endogenous
TC48
Treatment of cells with insulin-like growth factor (IGF) is
known to induce the activity of cellular tyrosine phosphatases to
modulate signaling pathways [41,42]. The ability of endoge-
nous tyrosine phosphatases to dephosphorylate pC3G was
examined by subjecting IMR-32 cells transfected with c-Src to
IGF treatment. As shown in Fig. 7A & B, IGF treatment
resulted in significant reduction in pC3G levels. Pretreatment of
cells with VO4 for 30 min prior to IGF treatment restored
pC3G staining, indicating that IGF induced repression of pC3G
was due to the activity of cellular tyrosine phosphatases
(Fig. 7C). Examination of total cellular pTyr levels showed no
significant difference upon IGF treatment in a majority of Src
induced tyrosine phosphorylated proteins indicating that pC3G
Figure 6. TC48 mediated C3G dephosphorylation is abrogated by vanadate. (A) C3G was immunoprecipitated from lysates of HEK293 cells
expressing C3G and GFP-Src with either TC48 or mTC48. Immunoprecipitation in TC48 expressing cells was carried out in the presence (VO4) or
absence (Utr) of sodium vanadate treatment. Along with lysates (WCL), the immunoprecipitates were subjected to Western blotting with the
indicated antibodies. A dotted line has been added in the pTyr blot to indicate that probing for the blots corresponding to C3G and Src were carried
out separately. C, control IgG. (B) IMR-32 cells expressing c-Src and GFP-TC48 were left untreated (Utr) or treated with vanadate (VO4) prior to fixation
and staining for c-Src and pC3G. In the presence of vanadate, TC48 expressing cell (arrow) shows pC3G.
doi:10.1371/journal.pone.0023681.g006
C3G Is a Substrate of TC-PTP
PLoS ONE | www.plosone.org 8 August 2011 | Volume 6 | Issue 8 | e23681Figure 7. IGF mediated dephosphorylation of C3G is dependent on endogenous TC48. (A) GFP-c-Src expressing IMR-32 cells were treated
with IGF prior to fixation and staining for pC3G. Utr, untreated. (B) Lysates of cells treated as in (A) were subjected to western blotting using the
indicated antibodies. (C) Pre-treatment with VO4 abrogates IGF induced dephosphorylation of C3G. GFP-c-Src expressing cells were subjected to IGF
treatment with or without VO4 pre-treatment for 30 min and stained for pC3G. Cells treated with VO4 alone are also shown. Bar, 10 mm. (D)
Expression of GFP-mTC48 along with c-Src, inhibits IGF induced dephosphorylation of C3G. IMR-32 cells were co-transfected with c-Src, and either
pCDNA or GFP-mTC48, subjected to IGF treatment and stained for Src and pC3G. Arrow indicates a cell co-expressing mTC48 along with c-Src
showing pC3G. (E) mTC48 expressing cells show Src induced pC3G irrespective of their exposure to IGF.
doi:10.1371/journal.pone.0023681.g007
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IGF (Fig. S7).
To examine the contribution of endogenous TC48, we tested
the presence of pC3G in c-Src expressing cells co-transfected with
mTC48. Catalytically inactive TC-PTP constructs have been
earlier shown to act as dominant negatives to inhibit the function
of endogenous TC48 [38,40]. We therefore examined pC3G levels
in mTC48 expressing cells upon IGF treatment. Cells co-
expressing c-Src with mTC48 showed pC3G staining upon IGF
treatment unlike cells expressing control vector (Fig. 7D). pC3G
staining was seen in mTC48 expressing cells in the presence or
absence of IGF (Fig. 7E). These results suggested that endogenous
TC-PTP could be stimulated to dephosphorylate endogenous
C3G upon IGF treatment.
TC48 inhibits forskolin induced C3G phosphorylation and
neurite growth
We have earlier shown that C3G is phosphorylated at the Golgi
dependent on endogenous SFK activation upon treatment of
IMR-32 cells with Fsk or NGF [12]. We therefore examined the
ability of TC-PTP to dephosphorylate C3G phosphorylated in
response to Fsk treatment. As shown in Fig. 8A, TC48 expressing
cells failed to show any pC3G in the Golgi unlike cells expressing
control vector, TC45 or mTC48. Fsk acts as a neurotrophin to
induce differentiation of IMR-32 cells and SFKs are known to
participate in the signaling responses [43]. To determine whether
TC48 overexpression, (because of its ability to repress C3G
phosphorylation), can affect neurite outgrowth induced by Fsk,
IMR-32 cells transfected with mTC48 or wild type TC48 were
subjected to Fsk treatment for 72 hrs to enable differentiation.
GFP expressing and non-expressing cells from the various fields
were examined for neurite growth. No difference was seen in cell
morphology between expressing and non-expressing cells not
treated with Fsk. In Fsk treated cells, mTC48 expression did not
affect the ability of Fsk to induce neurites, whereas TC48
expressing cells were significantly compromised in their ability to
grow neurites (Fig. 8B,C). These results indicate that TC48
overexpression can disrupt signaling induced by Fsk and disable
neuronal differentiation.
Discussion
Results from this study provide evidence for the identification of
C3G as an interacting partner and substrate of TC48. The ability
of TC-PTP to dephosphorylate C3G is dependent on its sub-
cellular localization since expression of the nuclear isoform, TC45
did not dephosphorylate C3G. Distinct sub-cellular localization to
defined cellular compartments often defines the role of PTPases in
specific biological functions and this is the first report of a Golgi
localized substrate for TC48. Evidence for C3G being a substrate
of TC48 has been provided based on the following findings: (1)
Better interaction between C3G and catalytically inactive TC48
which functions as a substrate trapping mutant, compared to WT
TC48 within mammalian cells. (2) Inhibition of interaction
between C3G and mTC48 by the phosphotyrosine mimetic,
sodium vanadate. (3) TC48 expression causes dephosphorylation
of endogenous C3G, but does not affect overall tyrosine
phosphorylation in cells. (4) Inhibition of cellular TC48 function
using a dominant negative mutant disables IGF mediated
dephosphorylation of C3G. (5) Vanadate treatment inhibits
TC48 mediated dephosphorylation of C3G.
C3G and TC48 appear to occupy distinct compartments, with
C3G showing a more diffused staining with higher levels in the
sub-cortical region and TC48 localizing in the nuclear membrane,
Golgi and ER. Nevertheless, C3G and TC48 complexes form in
the cellular context. Though C3G is distributed throughout the
cytoplasm, PV or Fsk induced pC3G staining is seen in the core of
the Golgi, indicating that either Golgi localized tyrosine kinases
mediate C3G phosphorylation in vivo or that phophorylated C3G
is targeted to the Golgi. Effectors of C3G function like Rap1 are
known to localize to the Golgi and have also been shown to be
specifically activated in distinct sub-cellular compartments [44].
Regulation of C3G activity at the Golgi could therefore be
mediated by dynamic shuttling of TC48 between the Golgi and
ER compartments aided through interaction with cargo receptors
p23 and p25 [29]. This may be a mechanism of regulating spatio-
temporal changes required for Golgi mediated functions during
neuronal differentiation [45]. c-Src localizes to the Golgi and is
also activated by PV and Fsk treatment [12,18]. Src induced NOG
is mediated by recruitment of Crk, a molecule that is constitutively
associated with C3G in cells [46]. We have therefore used c-Src
expression for studying phosphorylation dynamics of endogenous
C3G in the presence or absence of TC48. The lack of c-Src
induced pC3G in TC48 expressing cells may also be due to
inactivation of c-Src by TC-PTP [47]. Our observation of pTyr
staining that matched c-Src expression in TC48 or TC45
expressing cells indicated that TC48 may be specifically
dephosphorylating C3G and not altering c-Src kinase activity in
IMR-32 cells. Overexpression of PTPases is likely to cause
dephosphorylation of targets that may not be relevant as
physiological substrates. Our results showing that IGF treatment
induces dephosphorylation of C3G dependent on endogenous
TC48 provided evidence for C3G being a physiological substrate
of TC48.
Many TC-PTP substrates have been identified using substrate-
trap approaches, wherein interaction between the phosphatase
and its target is mediated through the catalytic domain and is
dependent on substrate phosphorylation. Proteins like p97, p23,
p25 and integrin a1, known to associate with non-catalytic
sequences of TC-PTP, function in regulating its activity and
localization [29,48,49]. Using in vitro binding assays, we have
identified that the C-terminal sequences of TC-PTP (350-381
amino acids) are sufficient for direct interaction with Crk binding
region of C3G. This region of C3G is known to interact with
SH3 domain containing molecules. Our study shows that it may
also be capable of other types of previously undefined
interactions. That stable interaction between full length TC-
PTP and C3G was partially dependent on the catalytic domain
was indicated by results showing that: 1) wild type TC48 differed
in interaction with C3G compared to its catalytically inactive
mutant, and 2) reduced interaction between mTC48 and
phosphorylated C3G in the presence of vanadate. It therefore
appears that the catalytic domain of TC-PTP may aid in the
stability of interaction with C3G, primarily mediated through its
non-catalytic sequences. This was evident from the fact that full
length TC-PTP isoforms interacted better with C3G-CBR in in-
vitro assays compared with the deletion constructs with only C-
terminal sequences.
Neurotransmitter induced neurite growth involves complex and
coordinated participation of a number of signaling proteins
[50,51]. A large number of cellular proteins are phosphorylated
on tyrosine during neuronal differentiation. PTPases have been
shown to be involved in neurite growth and differentiation
[52,53]. PTP sigma dephosphorylates neurotrophin receptors
and suppresses NOG [53]. C3G has been shown to be essential
for neuronal differentiation and knock-out animals show
enlarged brain cortical regions [25]. C3G is phosphorylated in
response to forskolin and NGF and TC-PTP expression inhibited
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PLoS ONE | www.plosone.org 10 August 2011 | Volume 6 | Issue 8 | e23681Figure 8. TC48 expression inhibits forskolin induced phosphorylation of C3G at the Golgi and neurite growth. (A) IMR-32 cells
transfected with pCDNA, GFP-TC45, GFP-TC48 or GFP-mTC48 were treated with forskolin for 2 hrs, fixed and stained for pC3G. Bar, 10 mm. (B) IMR-32
cells transfected with GFP-TC48 or GFP-mTC48 were left to grow in normal medium (Utr) or induced to differentiate by treatment with forskolin for
72 hrs (FSK). Cells were fixed and observed for neurite growth in GFP positive cells using a fluorescence microscope. (C) Quantitation of neurite
growth in GFP positive and negative cells after transfection with GFP-TC48 and GFP-mTC48 upon forskolin treatment. *p,0.01.
doi:10.1371/journal.pone.0023681.g008
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PLoS ONE | www.plosone.org 11 August 2011 | Volume 6 | Issue 8 | e23681forskolin induced differentiation of neuroblastoma cells depen-
dent on its catalytic activity. TC-PTP may be acting through
dephosphorylation of substrates required during neurite growth,
one of them being C3G. Expression of RPTP gamma was shown
to reduce levels of a 140 kDa protein and inhibit NOG induced
by NGF in PC12 cells [54]. Since C3G is phosphorylated on
tyrosine in response to NGF, it is possible that the 140 kDa
protein may be C3G. Overexpressed TC-PTP may be regulating
C3G effector functions, thereby inhibiting neuronal differentia-
tion. Earlier work showing that levels of TC-PTP are low in
adult brain also suggest a negative role for TC-PTP in
maintaining differentiation [55]. A role for TC-PTP has been
implicated in IGF induced phototransduction in retinal rod cells
[56]. Thus far, no defects in development and maturation of the
nervous system have been described in TC-PTP knock-out mice.
Both TC-PTP and C3G show ubiquitous expression and are
known to be involved in diverse signaling pathways. C3G may be
one of the substrates regulated by TC-PTP to maintain cellular
homeostasis.
These results describe the identification of the first intracellular
tyrosine phosphatase in the regulation of C3G. Interaction with,
and dephosphorylation by TC48 represents a novel mechanism of
C3G regulation that is physiologically significant in the context of
neurite growth in human neuroblastoma cells.
Supporting Information
Figure S1 C3G Crk binding region interacts with C-terminal
regulatory sequences of TC-PTP. TC45 and a deletion construct
of TC48, GFP-C66 (schematic shown in Fig. 1A) were used in in
vitro interaction assay. GST and GST-CBR coupled to glutathione
agarose beads were incubated with lysates of HEK-293 cells
expressing GFP-TC45 or GFP-C66. The WCL and washed beads
were subjected to western blotting for GFP. The recombinant
protein levels are shown in the Ponceau stained blot. M, protein
molecular weight markers. * indicates position of GFP-TC45 and
the GFP-C66 fusion proteins.
(TIF)
Figure S2 TC48 localizes predominantly to the ER & Golgi in
IMR-32 cells. IMR-32 cells expressing GFP-TC48 were stained
for Giantin (Golgi marker) (A) or ERGIC-53 (ER-Golgi interme-
diate compartment marker) (B). Panels show images of a single
section captured using 63X objective of Leica Confocal Micro-
scope (A) or using 40X Objective of Carl Zeiss, Axioimager Z1
upright microscope. Bar, 10 mm.
(TIF)
Figure S3 pY504-C3G antibody specifically recognizes C3G
phosphorylated on Y504. (A) Lysate of HEK293 cells expressing
GFP-Src with either WT C3G or Y504F mutant were subjected
to immunoprecipitation using control IgG or C3G antibody. The
immunoprecipitates were subjected to Western blotting along
with cell lysates (WCL) using the antibodies against pY504 C3G,
C3G and pTyr. The pC3G antibody recognizes WT-C3G from
cells co-expressing GFP-Src. No reaction is seen with Y504F
mutant, which is recognized by pTyr antibodies indicating that
this mutant is phosphorylated on tyrosine residues other than
Y504. A dotted line has been added in the pTyr blot to indicate
that probing of the blots corresponding to C3G and Src were
carried out seperately. Level of C3G is shown for comparison. (B)
Specificity of pC3G antibody to detect pY504 C3G in situ by
indirect immunofluorescence. IMR-32 cells were transfected with
C3G or Y504F mutant and left untreated (Utr) or subjected to
PV treatment (50 mM, 10 mins) and stained for C3G and pC3G.
Endogenous pC3G is seen in the Golgi and membrane of all PV
treated cells. WT C3G expressing cells show enhanced pC3G
staining in pervanadate (PV) treated cells whereas Y504F mutant
expressing cells do not. C3G and Y504F expressing cells are
indicated by arrows. No pC3G signal is seen in untreated cells.
Y504F mutant expressing cells show slightly weaker staining for
endogenous pC3G by virtue of its ability to function as a
dominant negative to inhibit phosphorylation of endogenous
C3G. Bar 10 mm.
(TIF)
Figure S4 pC3G is dephosphorylated by cellular tyrosine
phosphatases. IMR-32 cells were treated with PV (10 min,
50 mM) and left in normal medium (cDMEM) or medium
containing 50 mM sodium vanadate for 4 hrs. Cells were fixed
and stained for pC3G. Cells left in cDMEM show loss of pC3G
whereas enhanced levels of pC3G were seen upon exposure to
medium containing VO4. Bar, 10 mm. Utr: untreated cells.
(TIF)
Figure S5 TC48 inhibits PV induced pC3G in IMR32 and Cos-
1 cells: (A) IMR32 cells expressing HA-TC45 or HA-TC48 were
left untreated (Utr) or subjected to PV treatment and stained for
pC3G. TC45 expression has no effect on pC3G while TC48
expressing cells showed decreased pC3G staining. Bar, 10 mm.
(B,C) Cos-1 cells expressing GFP-TC45 or GFP-TC48 were left
untreated (Utr) or subjected to PV treatment and stained for
pC3G (B) and p-Tyr (C). While TC45 expression has no effect on
either pC3G or pTyr staining in cells, TC48 expressing cells
showed significantly less pC3G, but no difference in pTyr
staining.
(TIF)
Figure S6 TC-PTP expression does not affect c-Src induced
cellular pTyr. IMR-32 cells were transfected with c-Src along with
either GFP, GFP-TC48, GFP-mTC48, or GFP-TC45. Fixed cells
were stained to visualize expression of Src and pTyr. Images show
fields captured using a fluorescence microscope. Bar, 10 mm.
(TIF)
Figure S7 IGF treatment does not affect Src induced pTyr on
most cellular proteins. IMR-32 cells expressing GFP-Src were
either left untreated or subject to 100 nM IGF treatment prior to
preparation of whole cell lysates. Cell lysates were subject to
Western blotting to detect total cellular pTyr levels. GFP blotting
was performed to indicate expression of GFP-Src and CDK2 as
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